Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-13 to 2024-02-14
Current total value of award: $9398.84
Description: 4563643975!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML